Investor's Business Daily, October 4th, 2007
Nasdaq stocks edged up 0.2% as volume drifted lower. Many big-fund investors seem happy to wait for the September jobs report, due Friday morning, before buying any more.
Hansen Natural HANS, which became one of the hottest stocks of the 2003-2006 market, shot up 3.92 to 62.92, a new high, in more than three times its normal pace of business. The maker of the Monster energy drink is now 26% above its 50.08 buy point 18om a rebound off its 10-week moving average.
Morningstar MORN, which was featured in Thursday's Stocks In The News, leapt 5.01 to 69.68. Volume swelled to 21/2 times its usual. The gain took out its 67.26 buy point 18om a rebound off its 10-week line.
Team TISI, a small-cap provider of field-heat treatment, leak repair and other industrial services, flew ahead 3.23 to 30.97. Volume clocked in at almost four times its usual total.
The company reported 18 cents a share in its fiscal first quarter. That was 125% more than its year-ago result, and a nickel over views.
Team predicted it would earn between $1.05 and $1.15 in fiscal 2008. Views are running at $1.09.
Syntel SYNT bolted ahead 2.54 to 44.34, a new 52-week high, in three times its average volume.
Immucor BLUD surged 3.74 to a new high of 39 after reporting late Wednesday its second-quarter earnings easily beat views. The blood-test systems supplier had slipped 3% on heavy volume Wednesday.
LifeCell LIFC, a supplier of processed human tissue products for skin-graft procedures, rose 1.63 to 40.76 in brisk trade. But the stock got as high as 42.07, a new record, before pulling back and closing in the lower half of the day's trading range.
Small-cap genetics firm 3SBio SSRX fell 3.11 to 16.88 in hot trade. The stock had taken out an 18.20 buy point Wednesday from a cup-with-no-handle pattern, on even higher volume than Thursday's action.
An analyst at CIBC World Markets cut his rating on the stock to sector performer from sector outperformer, citing valuation.
China Finance Online JRJC fell 2.35 to 40.90 in double-paced action. Like 3SBio, China Finance is a foreign small-cap stock, which has been taking off like a rocket.
Unlike 3SBio, China Finance has not fallen below any buy points. Perhaps that is because it hasn't offered any entries since it broke out of a cup-with-no-handle over 13.28.
